# The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors

> **NCT07651020** · — · COMPLETED · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 1 (actual)

## Conditions studied

- Pancreatic Cancer
- Breast Cancer
- Lung Cancer
- Sarcoma
- Head and Neck Cancers
- Glioblastoma
- Colorectal Cancer
- Melanoma
- Ovarian Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Specific SPECT imaging agents targeting LRRC15

## Key facts

- **NCT ID:** NCT07651020
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-01
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2026-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07651020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07651020, "The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT07651020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*